COMPARE ROGAINE™ TO HAIRGENESIS®

The topical hair loss treatment drug Rogaine™, aka 2% / 5% minoxidil, was originally indicated for refractory hypertension.  Orally administered minoxidil lowers blood pressure by relaxing vascular smooth muscle through the action of its sulphated metabolite, minoxidil sulphate, as an opener of sarcolemmal potassium adenosine triphosphate (KATP) channels.  Its mechanism of action in those affected [...]

By |2018-11-13T01:36:41+00:00November 13th, 2018|Uncategorized|0 Comments

COMPARE PROPECIA™ TO HAIRGENESIS®

The oral hair loss treatment drug Propecia™, aka 1 mg finasteride, preferentially inhibits the type 2 isoform of the enzyme 5-alpha Reductase.  This enzyme, which converts the androgen hormone testosterone (T) into its more pathologic metabolite 5-alpha dihydrotestosterone (DHT) can be thought of as the match that lights the fuse in precipitating several disease phenotypes, [...]

By |2018-11-13T01:46:08+00:00October 29th, 2018|Uncategorized|0 Comments